{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:49:59Z","timestamp":1792698599187,"version":"4.5.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Kidney transplantation is the preferred treatment for suitable patients with end-stage renal disease; however, access to transplantation declines dramatically with increasing HLA sensitization. While the acceptable mismatch (AM) program by Eurotransplant improves transplantability for highly sensitized candidates, a clinically relevant subgroup with extremely low donor frequency or ineligible for AM remains disadvantaged. In carefully selected cases, the controlled delisting of unacceptable HLA antigens and the use of peri-transplant desensitization (e.g., imlifidase) may enable transplantation. In order to provide better guidance, this German expert consensus report was compiled by the Kidney and Immunology Commissions of the German Transplantation Society and the Organ Transplantation Commission of the German Society for Immunogenetics. Within the German legal framework of urgency and chances for success, the report proposes a practical guide for candidate selection, multidisciplinary governance, risk-adapted HLA delisting, assessment of organ offers, use of imlifidase, perioperative immunosuppression, prophylaxis for infection, post-transplant monitoring, and management of antibody-mediated rejection. These recommendations are intended for experienced transplant centers and aim to balance transplant opportunity against immunological risk in highly sensitized kidney transplant candidates. The primary scope of this article is highly sensitized adult wait-listed candidates considered for deceased-donor kidney transplantation after compatibility-preserving pathways have been exhausted or are unlikely to succeed; HLA-incompatible living-donor transplantation with imlifidase is addressed separately as a potential off-label scenario for selected highly sensitized patients.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1846251","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:33:43Z","timestamp":1780979623000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus report"],"prefix":"10.3389","volume":"17","author":[{"given":"Stefan","family":"Reuter","sequence":"first","affiliation":[{"name":"Department of Medicine D, Transplant Nephrology, University Hospital M\u00fcnster","place":["M\u00fcnster, Germany"]},{"name":"Deutsche Transplantationsgesellschaft (DTG) Kidney Commission","place":["Regensburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Benning","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Heidelberg University Hospital","place":["Heidelberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dick","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, Laboratory for Immunogenetics and Molecular Diagnostics, Ludwig-Maximilians-Universit\u00e4t (LMU) University Hospital Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa-Marie","family":"Dilz","sequence":"additional","affiliation":[{"name":"Institute of Transfusion Medicine, Laboratory for Transplantation Immunology, Leipzig University Hospital","place":["Leipzig, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla","family":"Einecke","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Section of Kidney Transplantation, University Medical Center G\u00f6ttingen","place":["G\u00f6ttingen, Germany"]},{"name":"Deutsche Transplantationsgesellschaft (DTG) Immunology Commission","place":["Regensburg, Germany"]},{"name":"Deutsche Gesellschaft f\u00fcr Immungenetik (DGI) Organ Transplantation Commission","place":["Regensburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Emmerich","sequence":"additional","affiliation":[{"name":"Institute for Transfusion Medicine and Gene Therapy, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg","place":["Freiburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Grahammer","sequence":"additional","affiliation":[{"name":"III. Department of Medicine, Nephrology\/Rheumatology\/Endocrinology, University Medical Center Hamburg-Eppendorf (UKE)","place":["Hamburg, Germany"]},{"name":"Hamburg Center for Kidney Health (HCKH), University Medical Center Hamburg-Eppendorf (UKE)","place":["Hamburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Gro\u00dfmann","sequence":"additional","affiliation":[{"name":"Institute of Transfusion Medicine, Stem Cell Donor Registry Leipzig, Leipzig University Hospital","place":["Leipzig, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Gwinner","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Halleck","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Medical Intensive Care, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hallensleben","sequence":"additional","affiliation":[{"name":"Institute for Transfusion Medicine and Transplant Engineering, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falko M.","family":"Heinemann","sequence":"additional","affiliation":[{"name":"Institute for Transfusion Medicine, Transplantation Diagnostics, University Hospital Essen","place":["Essen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"J\u00e4nigen","sequence":"additional","affiliation":[{"name":"Department of General and Visceral Surgery, Section of Transplantation Surgery, Medical Center \u2013 University of Freiburg","place":["Freiburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Kannenkeril","sequence":"additional","affiliation":[{"name":"Department of Medicine 4, Nephrology and Hypertension, University Hospital Erlangen","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Kauke","sequence":"additional","affiliation":[{"name":"Deutsche Transplantationsgesellschaft (DTG) Immunology Commission","place":["Regensburg, Germany"]},{"name":"Deutsche Gesellschaft f\u00fcr Immungenetik (DGI) Organ Transplantation Commission","place":["Regensburg, Germany"]},{"name":"Department of Thoracic Surgery, Lung Transplantation and Transplant Immunology, Ludwig-Maximilians-Universit\u00e4t (LMU) University Hospital Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Kelsch","sequence":"additional","affiliation":[{"name":"Deutsche Gesellschaft f\u00fcr Immungenetik (DGI) Organ Transplantation Commission","place":["Regensburg, Germany"]},{"name":"Institute of Transfusion Medicine and Cell Therapy, Laboratory for Immunogenetics\/Human Leukocyte Antigen (HLA), University Hospital M\u00fcnster","place":["M\u00fcnster, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Kemmner","sequence":"additional","affiliation":[{"name":"Transplant Center, LMU University Hospital Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte Andreas","family":"Kluger","sequence":"additional","affiliation":[{"name":"III. Department of Medicine, Nephrology\/Rheumatology\/Endocrinology, University Medical Center Hamburg-Eppendorf (UKE)","place":["Hamburg, Germany"]},{"name":"Hamburg Center for Kidney Health (HCKH), University Medical Center Hamburg-Eppendorf (UKE)","place":["Hamburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kowald","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Endocrinology, Nephrology, and Rheumatology, University of Leipzig Medical Center","place":["Leipzig, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kribben","sequence":"additional","affiliation":[{"name":"University Hospital Essen","place":["Essen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Lehmann","sequence":"additional","affiliation":[{"name":"Institute of Transfusion Medicine, Transplant Immunology, University Hospital Hamburg","place":["Hamburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Lindemann","sequence":"additional","affiliation":[{"name":"Deutsche Gesellschaft f\u00fcr Immungenetik (DGI) Organ Transplantation Commission","place":["Regensburg, Germany"]},{"name":"Institute for Transfusion Medicine, Transplantation Diagnostics, University Hospital Essen","place":["Essen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Maccagno","sequence":"additional","affiliation":[{"name":"Deutsche Gesellschaft f\u00fcr Immungenetik (DGI) Organ Transplantation Commission","place":["Regensburg, Germany"]},{"name":"Institute of Transfusion Medicine, Transplant Immunology, University Medical Center Mainz","place":["Mainz, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Morath","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Nuremberg Hospital and Paracelsus Medical Private University","place":["Nuremberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"M\u00fchlfeld","sequence":"additional","affiliation":[{"name":"Deutsche Transplantationsgesellschaft (DTG) Kidney Commission","place":["Regensburg, Germany"]},{"name":"Division of Nephrology and Immunology, Uniklinik Rheinisch-Westf\u00e4lische Technische Hochschule (RWTH) Aachen","place":["Aachen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien","family":"Pham","sequence":"additional","affiliation":[{"name":"Institute for Immunology, Transplantation Immunology, University Hospital Heidelberg","place":["Heidelberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Renders","sequence":"additional","affiliation":[{"name":"Department of Nephrology, TUM University Hospital Klinikum rechts der Isar, Technical University of Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schaub","sequence":"additional","affiliation":[{"name":"Deutsche Gesellschaft f\u00fcr Immungenetik (DGI) Organ Transplantation Commission","place":["Regensburg, Germany"]},{"name":"Clinic for Nephrology and Transplantation Immunology, University Hospital Basel","place":["Basel, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Scherer","sequence":"additional","affiliation":[{"name":"Deutsche Gesellschaft f\u00fcr Immungenetik (DGI) Organ Transplantation Commission","place":["Regensburg, Germany"]},{"name":"Institute for Immunology, Transplantation Immunology, University Hospital Heidelberg","place":["Heidelberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Seidl","sequence":"additional","affiliation":[{"name":"Deutsche Gesellschaft f\u00fcr Immungenetik (DGI) Organ Transplantation Commission","place":["Regensburg, Germany"]},{"name":"Institute of Transfusion Medicine and Immunohematology, University Hospital Frankfurt","place":["Frankfurt am Main, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Spriewald","sequence":"additional","affiliation":[{"name":"Deutsche Gesellschaft f\u00fcr Immungenetik (DGI) Organ Transplantation Commission","place":["Regensburg, Germany"]},{"name":"Laboratory of Immunogenetics (HLA Laboratory), Departments of Medicine 3 and 5, University Hospital Erlangen","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Stippel","sequence":"additional","affiliation":[{"name":"Deutsche Transplantationsgesellschaft (DTG) Kidney Commission","place":["Regensburg, Germany"]},{"name":"Department of General, Visceral, Tumor and Transplantation Surgery, University Hospital Cologne","place":["Cologne, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Stumpf","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine 3, University Hospital Carl Gustav Carus at the Technische Universit\u00e4t Dresden","place":["Dresden, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuong Hien","family":"Tran","sequence":"additional","affiliation":[{"name":"Institute for Immunology, Transplantation Immunology, University Hospital Heidelberg","place":["Heidelberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Weimer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nephrology and Renal Transplantation, University Hospital of Giessen and Marburg","place":["Giessen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Wilde","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Nephrology, University Hospital Essen, University of Duisburg-Essen","place":["Essen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Zecher","sequence":"additional","affiliation":[{"name":"Deutsche Transplantationsgesellschaft (DTG) Immunology Commission","place":["Regensburg, Germany"]},{"name":"Department of Nephrology, University Hospital Regensburg","place":["Regensburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Ziemann","sequence":"additional","affiliation":[{"name":"Deutsche Gesellschaft f\u00fcr Immungenetik (DGI) Organ Transplantation Commission","place":["Regensburg, Germany"]},{"name":"Institute of Transfusion Medicine, University Hospital Schleswig-Holstein","place":["L\u00fcbeck, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svitlana","family":"Ziganshyna","sequence":"additional","affiliation":[{"name":"Organ Donation Coordinator Unit, University of Leipzig Medical Center","place":["Leipzig, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Lachmann","sequence":"additional","affiliation":[{"name":"Deutsche Gesellschaft f\u00fcr Immungenetik (DGI) Organ Transplantation Commission","place":["Regensburg, Germany"]},{"name":"Institute of Transfusion Medicine, Tissue Typing\/Human Leukocyte Antigen (HLA), Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Budde","sequence":"additional","affiliation":[{"name":"Deutsche Transplantationsgesellschaft (DTG) Kidney Commission","place":["Regensburg, Germany"]},{"name":"Department of Nephrology and Medical Intensive Care, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.687254","article-title":"Highly sensitized patients are well served by receiving a compatible organ offer based on acceptable mismatches","volume":"12","author":"Heidt","year":"2021","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004687","article-title":"Immunized patients face reduced access to transplantation in the Eurotransplant Kidney Allocation System","volume":"107","author":"de Ferrante","year":"2023","journal-title":"Transplantation"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004238","article-title":"Impact of sensitization on waiting time prior to kidney transplantation in Germany","volume":"106","author":"Zecher","year":"2022","journal-title":"Transplantation"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaa271","article-title":"The ERA-EDTA Registry annual report 2018: A summary","volume":"14","author":"Kramer","year":"2021","journal-title":"Clin Kidney J"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2014530","article-title":"Long-term survival after kidney transplantation","volume":"385","author":"Hariharan","year":"2021","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1508380","article-title":"Survival benefit with kidney transplants from HLA-incompatible live donors","volume":"374","author":"Orandi","year":"2016","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2025.15497","article-title":"A prospective multicenter Luminex-based clinical algorithm to define unacceptable HLA mismatches before kidney transplantation: Consequences on outcome, waiting time, and wait list composition","volume":"38","author":"K\u00f6ppen","year":"2026","journal-title":"Transpl Int"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2022.10511","article-title":"European guideline for the management of kidney transplant patients with HLA antibodies: By the European Society for Organ Transplantation Working Group","volume":"35","author":"Mamode","year":"2022","journal-title":"Transpl Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.15.1883","article-title":"Kidney paired donation and optimizing the use of live donor organs","volume":"293","author":"Segev","year":"2005","journal-title":"JAMA"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0000000000001131","article-title":"Advances in desensitization for human leukocyte antigen incompatible kidney transplantation","volume":"29","author":"Vo","year":"2024","journal-title":"Curr Opin Organ Transplant"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/tan.14521","article-title":"Determination of unacceptable HLA antigen mismatches in kidney transplant recipients","volume":"100","author":"Ziemann","year":"2022","journal-title":"HLA"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2025.04.031","article-title":"A multicenter prospective cohort study evaluating impact of an active delisting strategy to enable kidney transplantation in wait-listed candidates with calculated panel reactive antibody \u226599.9","volume":"108","author":"Cucchiari","year":"2025","journal-title":"Kidney Int"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2025.08.003","article-title":"Delisting of HLA antigens as a possible strategy to enable transplantation in highly sensitized patients with a cPRA \u226599.9","volume":"108","author":"Cozzi","year":"2025","journal-title":"Kidney Int"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2024.110806","article-title":"Low-risk delisting strategy in highly sensitized patients without donor offers included in exchange donation programs: One single-center experience","volume":"85","author":"Comins-Boo","year":"2024","journal-title":"Hum Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612567","article-title":"IgG endopeptidase in highly sensitized patients undergoing transplantation","volume":"377","author":"Jordan","year":"2017","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003496","article-title":"Imlifidase desensitization in crossmatch-positive, highly sensitized kidney transplant recipients: Results of an international phase 2 trial (Highdes)","volume":"105","author":"Jordan","year":"2021","journal-title":"Transplantation"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2025.15425","article-title":"Five years follow-up of imlifidase desensitized kidney transplant recipients","volume":"38","author":"Lorant","year":"2025","journal-title":"Transpl Int"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16754","article-title":"Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients","volume":"21","author":"Kjellman","year":"2021","journal-title":"Am J Transplant"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2023.11244","article-title":"Imlifidase for kidney transplantation of highly sensitized patients with a positive crossmatch: The French consensus guidelines","volume":"36","author":"Couzi","year":"2023","journal-title":"Transpl Int"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000005388","article-title":"Belgian consensus guidelines within Eurotransplant on imlifidase-enabled deceased donor kidney transplantation in highly sensitized patients","volume":"109","author":"Kuypers","year":"2025","journal-title":"Transplantation"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2024.13886","article-title":"Desensitization with imlifidase for HLA-incompatible deceased donor kidney transplantation: A Delphi international expert consensus","volume":"37","author":"Furian","year":"2025","journal-title":"Transpl Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1159\/000538513","article-title":"Successful desensitization with imlifidase and daratumumab in a highly immunized, crossmatch-positive, blood group-incompatible living-donor re-transplant recipient with systemic lupus erythematosus and antiphospholipid syndrome","volume":"51","author":"Schrezenmeier","year":"2024","journal-title":"Transfus Med Hemother"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15486","article-title":"Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients","volume":"19","author":"Heidt","year":"2019","journal-title":"Am J Transplant"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2026.105578","article-title":"Germany's path to a national kidney exchange program: an assessment of the 2024 legislative proposal","volume":"166","author":"Bir\u00f3","year":"2026","journal-title":"Health Policy"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002432","article-title":"ENCKEP COST action. Building kidney exchange programmes in europe-an overview of exchange practice and activities","volume":"103","author":"Bir\u00f3","year":"2019","journal-title":"Transplantation"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.06.012","article-title":"Donor exchange programs in kidney transplantation: rationale and operational details from the north central donor exchange cooperative","volume":"57","author":"Akkina","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2024.02.008","article-title":"CAR T-cell therapy-paving the way for sensitized kidney transplant patients","volume":"105","author":"Jarmi","year":"2024","journal-title":"Kidney Int"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2024.111180","article-title":"Cars pick up another passenger: Organ transplantation","volume":"86","author":"Papadaki","year":"2025","journal-title":"Hum Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2026.01.020","article-title":"B-cell maturation antigen-Targeted T-cell Engager Therapy Combined with B-cell Depletion for Treatment of Refractory HLA Sensitization","author":"Leon","year":"2026","journal-title":"Kidney Int"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001817","article-title":"HLA diagnostics: Evaluating DSA strength by titration","volume":"102","author":"Tambur","year":"2018","journal-title":"Transplantation"},{"key":"B31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.trim.2013.09.005","article-title":"The complement interference phenomenon as a cause for sharp fluctuations of serum anti-HLA antibody strength in kidney transplant patients","volume":"29","author":"Guidicelli","year":"2013","journal-title":"Transpl Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: Evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229531","article-title":"Frailty predicts surgical complications after kidney transplantation. A propensity score matched study","volume":"15","author":"Dos Santos Mantovani","year":"2020","journal-title":"PloS One"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2018.03.056","article-title":"C3d assay in correlation with single antigen bead assay for human leukocyte antigen antibodies","volume":"50","author":"Ko","year":"2018","journal-title":"Transplant Proc"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2017.09.040","article-title":"Comparison between total IgG, C1q, and C3d single antigen bead assays in detecting class I complement-binding anti-HLA antibodies","volume":"49","author":"Moreno Gonzales","year":"2017","journal-title":"Transplant Proc"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000203","article-title":"Determinants of C1q binding in the single antigen bead assay","volume":"98","author":"Schaub","year":"2014","journal-title":"Transplantation"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/tan.70264","article-title":"Repeated HLA-DRB1 and HLA-DQB1 mismatches without preformed DSA affect graft survival, rejection and DSA development: A multicenter analysis","volume":"105","author":"van den Broek","year":"2025","journal-title":"HLA"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.304","article-title":"Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation","volume":"87","author":"Debout","year":"2015","journal-title":"Kidney Int"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2019.11.025","article-title":"Shorter cold ischemia time in deceased donor kidney transplantation reduces the incidence of delayed graft function especially among highly sensitized patients and kidneys from older donors","volume":"52","author":"Lauronen","year":"2020","journal-title":"Transplant Proc"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000888","article-title":"Impact of cold ischemia time on outcomes of deceased donor kidney transplantation: An analysis of a national registry","volume":"5","author":"Peters-Sengers","year":"2019","journal-title":"Transplant Direct"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1734705","article-title":"Case Report: Dual impact of daratumumab in early T-cell precursor acute lymphoblastic leukemia -- consolidation therapy achieves remission and eliminates donor-specific HLA antibodies","volume":"17","author":"Wong","year":"2026","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2025.12.283","article-title":"Dual targeting of B cell compartments using belatacept and daratumumab in highly sensitized kidney transplant candidates: A mechanistic proof-of-concept desensitization trial","author":"Malvezzi","year":"2026","journal-title":"Am J Transplant"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2024.08.020","article-title":"Open-label phase 1\/2 study of daratumumab-based desensitization before kidney transplantation","volume":"9","author":"Pilon","year":"2024","journal-title":"Kidney Int Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000005638","article-title":"Updates on kidney transplantation from the world transplant congress 2025","volume":"110","author":"Noble","year":"2026","journal-title":"Transplantation"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2025.07.009","article-title":"Anti-CD38 daratumumab treatment of chronic active antibody-mediated kidney allograft rejection","volume":"10","author":"Lye","year":"2025","journal-title":"Kidney Int Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2025.14343","article-title":"Targeting CD38 in antibody-mediated rejection","volume":"38","author":"Mayer","year":"2025","journal-title":"Transpl Int"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2400763","article-title":"A randomized phase 2 trial of felzartamab in antibody-mediated rejection","volume":"391","author":"Mayer","year":"2024","journal-title":"N Engl J Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000005374","article-title":"The fourth international consensus guidelines on the management of cytomegalovirus in solid organ transplantation","volume":"109","author":"Kotton","year":"2025","journal-title":"Transplantation"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2022.11.013","article-title":"Clinical recommendations for posttransplant assessment of anti-HLA donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document","volume":"23","author":"Lefaucheur","year":"2023","journal-title":"Am J Transplant"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2024.07.024","article-title":"Imlifidase in highly sensitized kidney transplant recipients with a positive crossmatch against a deceased donor","volume":"9","author":"Kamar","year":"2024","journal-title":"Kidney Int Rep"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2024.09.023","article-title":"Clinical utility of donor-derived cell-free DNA testing for kidney transplant monitoring in selected patients","volume":"107","author":"Budde","year":"2025","journal-title":"Kidney Int"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004212","article-title":"Combining donor-derived cell-free DNA fraction and quantity to detect kidney transplant rejection using molecular diagnoses and histology as confirmation","volume":"106","author":"Halloran","year":"2022","journal-title":"Transplantation"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaf097","article-title":"Antibody-mediated rejection-treatment standard","volume":"40","author":"B\u00f6hmig","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"B54","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/TP.0000000000004624","article-title":"The molecular phenotype of kidney transplants: Insights from the MMDx project","volume":"108","author":"Halloran","year":"2024","journal-title":"Transplantation"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000296","article-title":"Human leukocyte antigen-incompatible kidney transplantation after desensitization\u2014hope and reality","volume":"98","author":"Neumayer","year":"2014","journal-title":"Transplantation"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000298","article-title":"Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation","volume":"98","author":"Orandi","year":"2014","journal-title":"Transplantation"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03653-3","article-title":"Effect of felzartamab on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies","volume":"31","author":"Diebold","year":"2025","journal-title":"Nat Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/tan.15082","article-title":"A modeling approach for mean fluorescence intensity value harmonization and cutoff prediction for Luminex single antigen bead assays of two different vendors","volume":"102","author":"Karahan","year":"2023","journal-title":"HLA"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2021.112971","article-title":"Concordance with established tests and reproducibility of results obtained with a new single antigen chip array for HLA antibody detection (HISTO SPOT\u00ae HLA AB)","volume":"491","author":"Launhardt","year":"2021","journal-title":"J Immunol Methods"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/iji.12595","article-title":"An early evaluation of the HISTO SPOT\u00ae AB ID Class I & II test in cardiothoracic transplant patients","volume":"49","author":"Cashin","year":"2022","journal-title":"Int J Immunogenet"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/iji.12710","article-title":"Comparison of HISTO SPOT HLA AB with cross-match results","volume":"52","author":"Harris","year":"2025","journal-title":"Int J Immunogenet"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1846251\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:34:06Z","timestamp":1780979646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1846251\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":61,"alternative-id":["10.3389\/fimmu.2026.1846251"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1846251","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"article-number":"1846251"}}